Medifast
MED
#9395
Rank
A$0.20 B
Marketcap
A$18.59
Share price
-3.32%
Change (1 day)
9.44%
Change (1 year)

Earnings for Medifast (MED)

Earnings in 2026 (TTM): -A$50.55 Million

According to Medifast's latest financial reports the company's current earnings are A$0.29 Billion. In 2025 the company made an earning of -A$21.08 Million a decrease over its 2024 earnings that were of A$4.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Medifast from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$50.55 Million139.83%
2025 -A$21.08 Million-593.64%
2024 A$4.26 M-97.72%
2023 A$0.18 B-31.61%
2022 A$0.27 B-14.56%
2021 A$0.32 B61.25%
2020 A$0.19 B47.36%
2019 A$0.13 B31.82%
2018 A$0.10 B74.26%
2017 A$58.76 M47.56%
2016 A$39.82 M-6.36%
2015 A$42.53 M-16.28%
2014 A$50.8 M2%
2013 A$49.8 M44.4%
2012 A$34.49 M-16.75%
2011 A$41.43 M-12.14%
2010 A$47.15 M63.85%
2009 A$28.78 M136.71%
2008 A$12.15 M35.74%
2007 A$8.95 M-142.56%
2006 -A$21.05 Million-448.43%
2005 A$6.04 M35.62%
2004 A$4.45 M-16.51%
2003 A$5.33 M
2000 A$0.71 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 357.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Abeona Therapeutics
ABEO
-A$0.12 Billion 125.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bellerophon Therapeutics
BLPH
-A$16.37 Million-68.27%๐Ÿ‡บ๐Ÿ‡ธ USA